Suppr超能文献

内皮角膜移植术后角膜移植排斥反应的发生率及严重程度

Corneal transplant rejection rate and severity after endothelial keratoplasty.

作者信息

Allan Bruce D S, Terry Mark A, Price Francis W, Price Marianne O, Griffin Neil B, Claesson Margareta

机构信息

Moorfields Eye Hospital, London, UK.

出版信息

Cornea. 2007 Oct;26(9):1039-42. doi: 10.1097/ICO.0b013e31812f66e5.

Abstract

PURPOSE

To examine the corneal transplant rejection rate and the rate of graft failure subsequent to rejection in the first 2 years after endothelial keratoplasty (EK) and to compare this to background data for similar cases of penetrating keratoplasty (PK).

METHODS

Anonymized data from consecutive cases of EK [deep lamellar (DLEK) or Descemet stripping (DSEK)] for Fuchs corneal endothelial dystrophy or pseudophakic bullous keratopathy operated on before August 2004 were collected in 4 participating centers. The number and timing of rejection episodes and cases of subsequent graft failure were recorded, together with the time to cessation of topical steroid medication. Two-year postoperative findings were compared with background data for similar patients undergoing PK recorded in the Swedish Corneal Transplant Registry.

RESULTS

Rejection episodes were less frequent after EK than PK (P = 0.035). Fifteen (7.5%) of 199 EK cases had a rejection episode in the first 2 years after surgery versus 92 (13%) of 708 PK cases. Graft failure after rejection in EK may have been less frequent than in PK (P = 0.063), with only 1 (6.7%) case of rejection after EK versus 26 (28.3%) cases of rejection after PK proceeding to graft failure. A strong trend toward continued use of low-dose topical steroid medication was observed in the EK group. Eighty percent of EK patients were still taking topical steroid medication 2 years after surgery, whereas topical steroid medication had been ceased within a year of surgery in almost all PK patients in the comparator group.

CONCLUSIONS

Corneal transplant rejection is less frequent and may be less severe after EK than after PK. It is not yet clear whether these apparent differences are simply a product of relatively prolonged postoperative topical steroid cover in EK patients.

摘要

目的

研究内皮角膜移植术(EK)后前2年的角膜移植排斥率以及排斥反应后的移植失败率,并将其与穿透性角膜移植术(PK)类似病例的背景数据进行比较。

方法

收集2004年8月之前在4个参与中心接受手术治疗的、因Fuchs角膜内皮营养不良或假晶状体大泡性角膜病变而行连续EK手术(深板层角膜内皮移植术[DLEK]或后弹力层剥除角膜内皮移植术[DSEK])的匿名数据。记录排斥反应发作的次数和时间以及随后发生移植失败的病例,同时记录局部类固醇药物停用的时间。将术后2年的结果与瑞典角膜移植登记处记录的接受PK治疗的类似患者的背景数据进行比较。

结果

EK术后排斥反应发作的频率低于PK(P = 0.035)。199例EK病例中有15例(7.5%)在术后前2年发生排斥反应,而708例PK病例中有92例(13%)发生排斥反应。EK排斥反应后移植失败的频率可能低于PK(P = 0.063),EK术后仅有1例(6.7%)排斥反应病例进展为移植失败,而PK术后有26例(28.3%)排斥反应病例进展为移植失败。在EK组中观察到持续使用低剂量局部类固醇药物的强烈趋势。80%的EK患者在术后2年仍在使用局部类固醇药物,而对照组中几乎所有PK患者在术后1年内就停止了局部类固醇药物治疗。

结论

与PK相比,EK后角膜移植排斥反应的频率较低,且可能不太严重。目前尚不清楚这些明显差异是否仅仅是由于EK患者术后局部类固醇药物覆盖时间相对延长所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验